CONMED Corporation to Announce First Quarter 2025 Financial Results on April 30, 2025
CONMED (NYSE: CNMD) has scheduled its first quarter 2025 financial results announcement for April 30, 2025, after market close. The company will host a conference call at 4:30 p.m. ET on the same day to discuss the quarterly performance. Interested participants can pre-register to obtain dial-in details and passcode. The call will also be available via webcast through CONMED's investor relations website, with a replay accessible approximately one hour after the call conclusion.
CONMED (NYSE: CNMD) ha programmato l'annuncio dei risultati finanziari per il primo trimestre del 2025 per 30 aprile 2025, dopo la chiusura del mercato. L'azienda terrà una conferenza telefonica alle 16:30 ET nello stesso giorno per discutere le performance trimestrali. I partecipanti interessati possono registrarsi in anticipo per ottenere i dettagli per la chiamata e il codice di accesso. La chiamata sarà inoltre disponibile in webcast attraverso il sito web delle relazioni con gli investitori di CONMED, con una registrazione accessibile circa un'ora dopo la conclusione della chiamata.
CONMED (NYSE: CNMD) ha programado el anuncio de resultados financieros para el primer trimestre de 2025 para el 30 de abril de 2025, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica a las 4:30 p.m. ET el mismo día para discutir el rendimiento trimestral. Los participantes interesados pueden registrarse previamente para obtener los detalles de la llamada y el código de acceso. La llamada también estará disponible a través de un webcast en el sitio web de relaciones con inversores de CONMED, con una repetición accesible aproximadamente una hora después de la conclusión de la llamada.
CONMED (NYSE: CNMD)는 2025년 4월 30일에 시장 마감 후 2025년 1분기 재무 결과 발표를 예정하고 있습니다. 회사는 같은 날 오후 4시 30분 ET에 분기 성과에 대해 논의하기 위해 컨퍼런스 콜을 개최할 것입니다. 관심 있는 참가자는 사전 등록하여 전화 접속 세부정보와 비밀번호를 받을 수 있습니다. 이 통화는 CONMED의 투자자 관계 웹사이트를 통해 웹캐스트로도 제공되며, 통화 종료 약 1시간 후에 재생이 가능합니다.
CONMED (NYSE: CNMD) a programmé l'annonce de ses résultats financiers pour le premier trimestre 2025 pour le 30 avril 2025, après la fermeture du marché. L'entreprise tiendra une conférence téléphonique le même jour à 16h30 ET pour discuter de la performance trimestrielle. Les participants intéressés peuvent s'inscrire à l'avance pour obtenir les détails de connexion et le code d'accès. L'appel sera également disponible par webcast via le site web des relations investisseurs de CONMED, avec un enregistrement accessible environ une heure après la fin de l'appel.
CONMED (NYSE: CNMD) hat die Bekanntgabe der finanziellen Ergebnisse für das erste Quartal 2025 auf den 30. April 2025 nach Börsenschluss terminiert. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz abhalten, um die Quartalsleistung zu besprechen. Interessierte Teilnehmer können sich im Voraus registrieren, um die Einwahldaten und den Zugangscode zu erhalten. Die Konferenz wird auch über einen Webcast auf der Investor-Relations-Website von CONMED verfügbar sein, mit einer Wiederholung, die etwa eine Stunde nach dem Ende des Anrufs zugänglich ist.
- None.
- None.
To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode.
This conference call will also be webcast and can be accessed from the “Investors” section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
About CONMED Corporation
CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.
Forward-Looking Statements
This press release and associated conference call may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2024 and other risks and uncertainties, which may be detailed from time to time in reports filed by CONMED with the SEC. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250402497025/en/
CONMED Corporation
Todd W. Garner
Chief Financial Officer
727-214-2975
ToddGarner@conmed.com
Source: CONMED Corporation
FAQ
When will CONMED (CNMD) release Q1 2025 earnings?
What time is CONMED's Q1 2025 earnings conference call?
How can investors access CONMED's Q1 2025 earnings call?
Will CONMED's Q1 2025 earnings call be available for replay?
